NCT03714997

Brief Summary

The goal of this study is to identify the comparative efficacy of high-intensity walking training in individuals with chronic, motor incomplete spinal cord injury as compared to lower-intensity walking exercise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 22, 2018

Completed
8 months until next milestone

Study Start

First participant enrolled

July 1, 2019

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 7, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 7, 2025

Completed
Last Updated

January 16, 2026

Status Verified

January 1, 2026

Enrollment Period

5.5 years

First QC Date

July 25, 2018

Last Update Submit

January 15, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Fastest overground walking speed

    fastest walking speed during 10 m walk test

    Changes from baseline to post-testing at 8 weeks

  • peak treadmill speed

    fastest treadmill speed reached for 1 full minute on graded exercise test

    Changes from baseline to post-testing at 8 weeks

Secondary Outcomes (2)

  • 6 min walk test

    Changes from baseline to post-testing at 8 weeks

  • self-selected speed

    Changes from baseline to post-testing at 8 weeks

Study Arms (2)

High Intensity Locomotor Training

EXPERIMENTAL

High Intensity Locomotor Training will consist of 30 sessions of walking related activities in variable contexts (i..e, on a treadmill, overground, and on stairs), with a primary goal to achieve 40 minutes of walking within 1 hour sessions while achieving heart rates close to 80% of heart rate reserve.

Procedure: Walking training

Low Intensity Locomotor Training

ACTIVE COMPARATOR

High Intensity Locomotor Training will consist of 30 sessions of walking related activities in variable contexts (i..e, on a treadmill, overground, and on stairs), with a primary goal to achieve 40 minutes of walking within 1 hour sessions while achieving heart rates from 30% to 40% of heart rate reserve.

Procedure: Walking training

Interventions

Practice of walking training in variable contexts, including multiple tasks and environments specific to the patients' deficits and community walking goals.

Also known as: Locomotor training, Walking Exercise, Gait Training
High Intensity Locomotor TrainingLow Intensity Locomotor Training

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals with motor incomplete SCI (AIS C or D) \> 12 mo. duration will be recruited to participate in the study, with further criteria including anatomical lesions between C1-T10..
  • Participants will be between 18 and 75 years of age (note: while participants \> 50 yrs with subacute SCI have a reduced probability of functional ambulation 79, participants will already be ambulatory with only minimal or no assistance and in the chronic phase of rehabilitation, and prediction rules using age will not necessarily apply in this study).
  • All participants must be able to perform walking training with passive range of motion within the limits of normal locomotor function, including: 0-30 degrees ankle plantarflexion, knee flexion from 0 to 90 degrees, hip flexion to 0-90 degrees.

You may not qualify if:

  • Participants with body mass \> 400 lbs will be excluded, which is the highest limit for use of our motorized treadmill and safety harness systems.
  • Participants will be medically stable with medical clearance to participate, with absence of concurrent severe medical illness including: unhealed decubiti, existing infection, significant cardiovascular or metabolic disease which limits exercise participation, significant osteoporosis (as indicated by history of fractures following injury), active heterotrophic ossification in the lower extremities, known history of peripheral nerve injury in lower legs, history of traumatic brain injury, and history of pulmonary complications that limits exercise capacity, including significant obstructive and/or restrictive lung diseases.
  • Participants who are ventilator-dependent will be excluded secondary to severely impaired respiratory capacity.
  • Participants with substantial orthopedic bracing to stabilize the cervical or thoracic vertebral column are not eligible due to safety concerns with harness supported ambulation training..
  • Patients will also be excluded if they are unable to tolerate 10 minutes of standing without orthostasis (decrease in blood pressure by 20 mmHg systolic and 10 mmHg diastolic); previous experience in the sub-acute population suggests that 10 minutes of standing is more than sufficient for tolerating 45 minutes of walking secondary to increased activity/muscle pump minimizing risk for orthostasis.
  • Individuals who are undergoing concurrent physical therapy will be excluded from the study population to eliminate confounding effects of additional physical interventions, Other therapies, such as occupational or speech therapies, will be allowed as prescribed by their physician. Individuals will be allowed and encouraged to continue their normal exercise routines during the course of the intervention, with activity monitors measuring stepping activity in all participants
  • Women of childbearing potential will not be excluded, although women who are pregnant or who are considering becoming pregnant will be excluded due to the trunk and pelvis restraints required for use during locomotion.
  • All subjects prescribed oral anti-spastic medications will not be excluded, although patients with intrathecal baclofen pumps or history of recent (\< 3 months) botulinum toxin injection in the lower extremities will be excluded due to potential increases in weakness interfering with the effects of stepping training performance.
  • Patients with a known history of autonomic dysreflexia will not be excluded, although specific signs and symptoms of all patients with history of injury \> T6 anatomical level will be closely monitored throughout training.
  • Other criteria
  • Men and women will be recruited for participation in the proposed clinical trial at rates consistent with national and local average of gender disparities of SCI (80% male, 20% women). Women of childbearing potential will not be excluded, although women who are pregnant or who are considering becoming pregnant will be excluded due to the trunk and pelvis restraints required for use during locomotion.
  • Individuals of different ethnicities will be recruited at rates similar to the national and local ethnicity rates. Current data since 2005 indicate that of the entire population of SCI, 66.1% are Caucasian, 27.1% are African American, 6.6% are of Hispanic origin, and 2.0% Asian. These populations closely resemble those at RHI and in our previous studies in human SCI.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehabilitation Hospital of Indiana

Indianapolis, Indiana, 46254-2607, United States

Location

Related Publications (1)

  • Hornby TG, Plawecki A, Lotter J, Shoger L, Voigtmann C, Heffron L, Lucas E, Parrott D, Henderson CE. Higher Intensity Walking Training in Individuals With Chronic Motor Incomplete Spinal Cord Injury: A Randomized Clinical Trial. Neurorehabil Neural Repair. 2026 Jan;40(1):49-60. doi: 10.1177/15459683251399158. Epub 2025 Dec 27.

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Thomas G Hornby

    Indiana University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Blinded outcomes assessment at each measures phase
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel design randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Physical Medicine

Study Record Dates

First Submitted

July 25, 2018

First Posted

October 22, 2018

Study Start

July 1, 2019

Primary Completion

January 7, 2025

Study Completion

January 7, 2025

Last Updated

January 16, 2026

Record last verified: 2026-01

Locations